In Vivo Ubiquinone Reduction Levels during Thermogenesis in Araceae

In vivo ubiquinone (UQ) reduction levels were measured during the development of the inflorescences of Arum maculatum and Amorphophallus krausei. Thermogenesis in A. maculatum spadices appeared not to be confined to a single developmental stage, but occurred during various stages. The UQ pool in both A. maculatum and A. krausei appendices was approximately 90% reduced during thermogenesis. Respiratory characteristics of isolated appendix mitochondria did not change in the period around thermogenesis. Apparently, synthesis of the required enzyme capacity is regulated via a coarse control upon which a fine control of metabolism that regulates the onset of thermogenesis is imposed.     

Membrane-type 1 Matrix Metalloproteinase Regulates Macrophage-dependent Elastolytic Activity and Aneurysm Formation in Vivo

During arterial aneurysm formation, levels of the membrane-anchored matrix metalloproteinase, MT1-MMP, are elevated dramatically. Although MT1-MMP is expressed predominately by infiltrating macrophages, the roles played by the proteinase in abdominal aortic aneurysm (AAA) formation in vivo remain undefined. Using a newly developed chimeric mouse model of AAA, we now demonstrate that macrophage-derived MT1-MMP plays a dominant role in disease progression. In wild-type mice transplanted with MT1-MMP-null marrow, aneurysm formation induced by the application of CaCl₂ to the aortic surface was almost completely ablated. Macrophage infiltration into the aortic media was unaffected by MT1-MMP deletion, and AAA formation could be reconstituted when MT1-MMP^+/+ macrophages, but not MT1-MMP^+/+ lymphocytes, were infused into MT1-MMP-null marrow recipients. In vitro studies using macrophages isolated from either WT/MT1-MMP^-/- chimeric mice, MMP-2-null mice, or MMP-9-null mice demonstrate that MT1-MMP alone plays a dominant role in macrophage-mediated elastolysis. These studies demonstrate that destruction of the elastin fiber network during AAA formation is dependent on macrophage-derived MT1-MMP, which unexpectedly serves as a direct-acting regulator of macrophage proteolytic activity.Development and progression of abdominal aortic aneurysm (AAA)² is a complex process that, untreated, can lead to tissue failure, hemorrhage, and death (1). Destruction of the orderly elastin lamellae of the vessel wall is considered the sine qui non of arterial aneurysm formation (2) as adult tissues cannot regenerate normal elastin fibers (3). Moreover, the elastin degradation products are chemotactic for inflammatory cells and serve to amplify the local injury (4). Although several types of elastolytic proteases are elevated in AAA tissue (5-9), studies using murine models of AAA and targeted protease deletion suggest that matrix metalloproteinases (MMPs), particularly the secreted proteases, MMP-2 and MMP-9, play key roles in the pathologic remodeling of the elastin lamellae that lead to AAA (7, 8).Membrane-type 1 MMP (MT1-MMP) is the prototypical member of a family of membrane-tethered MMPs (10). Recent studies indicate that MT1-MMP expression is elevated in human AAA tissues and that infiltrating macrophages are the primary source of the proteinase in aortic lesions (11-13). Although indirect evidence suggests that MT1-MMP may participate in the control of monocyte/macrophage motile responses as well as interactions with the vessel wall during transmigration (14, 15), the role(s) played by MT1-MMP in regulating macrophage proteolytic activity or AAA formation in vivo remains undefined.Using a murine model of AAA and mice with a targeted deletion of MT1-MMP in myelogenous cell populations, we now demonstrate that macrophage-derived MT1-MMP is required for elastin degradation and aneurysm formation. Importantly, macrophages are not dependent on MT1-MMP for infiltrating aortic tissues but instead use the protease to directly regulate their elastolytic potential in an MMP-2- and MMP-9-independent fashion. These studies define a new and unexpected role for MT1-MMP in controlling macrophage elastolytic activity in the in vitro and in vivo settings.     

Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo

Insulin signaling is essential for normal glucose homeostasis. Rho-kinase (ROCK) isoforms have been shown to participate in insulin signaling and glucose metabolism in cultured cell lines. To investigate the physiological role of ROCK1 in the regulation of whole body glucose homeostasis and insulin sensitivity in vivo, we studied mice with global disruption of ROCK1. Here we show that, at 16–18 weeks of age, ROCK1-deficient mice exhibited insulin resistance, as revealed by the failure of blood glucose levels to decrease after insulin injection. However, glucose tolerance was normal in the absence of ROCK1. These effects were independent of changes in adiposity. Interestingly, ROCK1 gene ablation caused a significant increase in glucose-induced insulin secretion, leading to hyperinsulinemia. To determine the mechanism(s) by which deletion of ROCK1 causes insulin resistance, we measured the ability of insulin to activate phosphatidylinositol 3-kinase and multiple distal pathways in skeletal muscle. Insulin-stimulated phosphatidylinositol 3-kinase activity associated with IRS-1 or phospho-tyrosine was also reduced ∼40% without any alteration in tyrosine phosphorylation of insulin receptor in skeletal muscle. Concurrently, serine phosphorylation of IRS-1 at serine 632/635, which is phosphorylated by ROCK in vitro, was also impaired in these mice. Insulin-induced phosphorylation of Akt, AS160, S6K, and S6 was also decreased in skeletal muscle. These data suggest that ROCK1 deficiency causes systemic insulin resistance by impairing insulin signaling in skeletal muscle. Thus, our results identify ROCK1 as a novel regulator of glucose homeostasis and insulin sensitivity in vivo, which could lead to new treatment approaches for obesity and type 2 diabetes.The ability of insulin to acutely stimulate glucose uptake and metabolism in peripheral tissues such as skeletal muscle and adipose tissue is critical for the regulation of normal glucose homeostasis (1). Impairments in insulin secretion and in the response of peripheral tissues to insulin (i.e. insulin resistance) are major pathogenic features of type 2 diabetes and contribute to the morbidity of obesity (1, 2). Insulin action involves a series of signaling cascades initiated by insulin binding to its receptor, eliciting receptor autophosphorylation and activation of the receptor tyrosine kinase, resulting in tyrosine phosphorylation of insulin receptor substrates (IRSs)⁴ (3). Phosphorylation of IRSs leads to activation of phosphatidylinositol 3-kinase (PI3K) and subsequently to activation of Akt and its downstream mediator AS160, all of which are important steps for the stimulation of glucose transport induced by insulin (4–6). Although the mechanism(s) underlying insulin resistance are not completely understood in peripheral tissues such as skeletal muscle, they are thought to result, at least in part, from impaired insulin-stimulated signal transduction (7).Rho-kinase (ROCK) is a Ser/Thr protein kinase identified as a GTP-Rho-binding protein (8). There are two isoforms of Rhokinase, ROCK1 (also known as ROCKβ) (9, 10) and ROCK2 (also known as ROCKα) (9, 11). ROCK activity is enhanced by binding with RhoA GTP through a Rho-binding domain (8). Insulin activates geranylgeranyltranferase and increases the cellular amounts of geranlygeranylated RhoA, leading to increased RhoA activity (12). ROCK plays important roles in many cellular processes, including signal transduction, vesicle trafficking, and cytoskeletal organization (13, 14), key processes involved in insulin-stimulated glucose transport in myocytes and adipocytes (15–17). Previous studies have indicated that ROCK chemical inhibition is beneficial for reversing certain disease abnormalities in hypertension and diabetic nephropathy (18–20). Studies of the effects of ROCK inhibitors on glucose homeostasis in animals have yielded conflicting results, however. In obese Zucker rats, chronic treatment with the ROCK inhibitor fasudil decreases blood pressure and improves glucose tolerance (21). However, very recently, chronic treatment of obese db/db mice with the inhibitor fasudil was reported to have no effect on blood glucose levels (20). In contrast, in normal mice, we found that acute treatment with ROCK inhibitor Y-27632 causes insulin resistance in vivo by reducing insulin-mediated glucose uptake in skeletal muscle (22). In support of this, our previous work demonstrated that overexpression of dominant negative ROCK decreases insulin-stimulated glucose transport in L6 muscle cells, isolated soleus muscle ex vivo, and 3T3-L1 adipocytes via impairing PI3K activity (22). However, the use of different inhibitors, doses, treatment times, and animal models in these in vivo animal studies limits understanding of the roles of ROCK in regulating glucose homeostasis and insulin sensitivity in vivo. The fact that ROCK inhibitors target both ROCK isoforms and that their specificities may not be absolute further complicates interpretation of these studies (23).In this study, we examined the physiological role of ROCK1 in the regulation of glucose homeostasis, whole body insulin sensitivity, and insulin action in mice with particular emphasis on the molecular basis of insulin resistance. Here we provide the evidence that global ROCK1 deficiency in mice causes insulin resistance in vivo in part via serine 632/635 phosphorylation of IRS-1. These data identify ROCK1 as a novel regulator of whole body glucose homeostasis and insulin signaling in vivo.     

An Alternative Form of Replication Protein A Prevents Viral Replication in Vitro

Replication protein A (RPA), the eukaryotic single-stranded DNA-binding complex, is essential for multiple processes in cellular DNA metabolism. The “canonical” RPA is composed of three subunits (RPA1, RPA2, and RPA3); however, there is a human homolog to the RPA2 subunit, called RPA4, that can substitute for RPA2 in complex formation. We demonstrate that the resulting “alternative” RPA (aRPA) complex has solution and DNA binding properties indistinguishable from the canonical RPA complex; however, aRPA is unable to support DNA replication and inhibits canonical RPA function. Two regions of RPA4, the putative L34 loop and the C terminus, are responsible for inhibiting SV40 DNA replication. Given that aRPA inhibits canonical RPA function in vitro and is found in nonproliferative tissues, these studies indicate that RPA4 expression may prevent cellular proliferation via replication inhibition while playing a role in maintaining the viability of quiescent cells.Replication protein A (RPA)³ is a stable complex composed of three subunits (RPA1, RPA2, and RPA3) that binds single-stranded DNA (ssDNA) nonspecifically. RPA (also referred to as canonical RPA) is essential for cell viability (1), and viable missense mutations in RPA subunits can lead to defects in DNA repair pathways or show increased chromosome instability. For example, a missense change in a high affinity DNA-binding domain (DBD) was demonstrated to cause a high rate of chromosome rearrangement and lymphoid tumor development in heterozygous mice (2). RPA has also been shown to have increased expression in colon and breast cancers (3, 4). High RPA1 and RPA2 levels in cancer cells are also correlated with poor overall survival (3, 4), which is consistent with RPA having a role in efficient cell proliferation.RPA is a highly conserved complex as all eukaryotes contain homologs of each of the three RPA subunits (1). At least some plants (e.g. rice) and some protists (e.g. Cryptosporidium parvum) contain multiple genes encoding for subunits of RPA (5, 6). In rice, there is evidence for multiple RPA complexes that are thought to perform different cellular functions (5). In contrast, only a single alternative form of RPA2, called RPA4, has been identified in humans (7). RPA4 was originally identified as a protein that interacts with RPA1 in a yeast two-hybrid screen (7). The RPA4 subunit is 63% identical/similar to RPA2. Comparison of the sequences of RPA4 and RPA2 suggests that the two proteins have a similar domain organization.⁴ RPA4 appears to contain a putative core DNA-binding domain (DBD G) flanked by a putative N-terminal phosphorylation domain and a C terminus containing a putative winged-helix domain (Fig. 1A). The RPA4 gene is located on the X chromosome, intronless, and found mainly in primates.⁴ Initial characterization of RPA4 by Keshav et al. (7) indicated that either RPA2 or RPA4, but not both simultaneously, interacts with RPA1 and RPA3 to form a complex. This analysis also showed that RPA4 is expressed in placenta and colon tissue but was either not detected or expressed at low levels in most established cell lines examined (7).Open in a separate windowFIGURE 1.Properties of aRPA complex. A, schematic diagram of the structural and functional domains of the three subunits of RPA and (proposed for) RPA4: DNA-binding domains (DBD A-G), the phosphorylation domain (PD), winged-helix domain (WH), and linker regions (lines). The sequence similarity between RPA2 and RPA4 is indicated for each domain of the subunit. B, gel analysis of 2 μg of RPA4/3, RPA. or aRPA separated on 8-14% SDS-PAGE gels and visualized by Coomassie Blue staining. The position of each RPA subunit is indicated. C, hydrodynamic properties of aRPA and RPA complexes. The sedimentation coefficient and Stokes'' radius were determined as described previously by sedimentation on a 15-35% glycerol gradient and chromatography on a Superose 6 10/300 GL column (GE Healthcare), respectively (13). Mass and frictional coefficients were calculated using the method of Siegal and Monty (8). The predicted mass was based upon the amino acid sequence derived from the DNA sequence.These studies describe the purification and functional analysis of an alternative RPA (aRPA) complex containing RPA1, RPA3, and RPA4. The aRPA complex is a stable heterotrimeric complex similar in size and stability to the canonical RPA complex (RPA1, RPA3, and RPA2). aRPA interacts with ssDNA in a manner indistinguishable from canonical RPA; however, it does not support DNA replication in vitro. Mixing experiments demonstrate that aRPA also inhibits canonical RPA from functioning in DNA replication. Hybrid protein studies paired with structural modeling have allowed for the identification of two regions of RPA4 responsible for this inhibitory activity. Data presented here are consistent with recent analyses of RPA4 function in human cells,⁴ and we conclude that RPA4 has anti-proliferative properties and has the potential to play a regulatory role in human cell proliferation through the control of DNA replication.     

Domains of a Transit Sequence Required for in Vivo Import in Arabidopsis Chloroplasts

Nuclear-encoded precursors of chloroplast proteins are synthesized with an amino-terminal cleavable transit sequence, which contains the information for chloroplastic targeting. To determine which regions of the transit sequence are most important for its function, the chloroplast uptake and processing of a full-length ferredoxin precursor and four mutants with deletions in adjacent regions of the transit sequence were analyzed. Arabidopsis was used as an experimental system for both in vitro and in vivo import. The full-length wild-type precursor translocated efficiently into isolated Arabidopsis chloroplasts, and upon expression in transgenic Arabidopsis plants only mature-sized protein was detected, which was localized inside the chloroplast. None of the deletion mutants was imported in vitro. By analyzing transgenic plants, more subtle effects on import were observed. The most N-terminal deletion resulted in a fully defective transit sequence. Two deletions in the middle region of the transit sequence allowed translocation into the chloroplast, although with reduced efficiencies. One deletion in this region strongly reduced mature protein accumulation in older plants. The most C-terminal deletion was translocated but resulted in defective processing. These results allow the dissection of the transit sequence into separate functional regions and give an in vivo basis for a domain-like structure of the ferredoxin transit sequence.     

Tyrosylprotein Sulfotransferase-2 Expression Is Required for Sulfation of RNase 9 and Mfge8 in Vivo

Protein-tyrosine sulfation is mediated by two Golgi tyrosyl-protein sulfotransferases (TPST-1 and TPST-2) that are widely expressed in vivo. However, the full substrate repertoire of this enzyme system is unknown and thus, our understanding of the biological role(s) of tyrosine sulfation is limited. We reported that whereas Tpst1^-/- male mice have normal fertility, Tpst2^-/- males are infertile despite normal spermatogenesis. However, Tpst2^-/- sperm are severely defective in their motility in viscous media and in their ability to fertilize eggs. These findings suggest that sulfation of unidentified substrate(s) is crucial for normal sperm function. We therefore sought to identify tyrosine-sulfated proteins in the male genital tract using affinity chromatography on PSG2, an anti-sulfotyrosine monoclonal antibody, followed by mass spectrometry. Among the several candidate tyrosine-sulfated proteins identified, RNase 9 and Mfge8 were examined in detail. RNase 9, a catalytically inactive RNase A family member of unknown function, is expressed only in the epididymis after onset of sexual maturity. Mfge8 is expressed on mouse sperm and Mfge8^-/- male mice are subfertile. Metabolic labeling coupled with sulfoamino acid analysis confirmed that both proteins are tyrosine-sulfated and both proteins are expressed at comparable levels in wild type, Tpst1^-/-, and Tpst2^-/- epididymides. However, we demonstrate that RNase 9 and Mfge8 are tyrosine-sulfated in wild type and Tpst1^-/-, but not in Tpst2^-/- mice. These findings suggest that lack of sulfation of one or both of these proteins may contribute mechanistically to the infertility of Tpst2^-/- males.Protein-tyrosine sulfation is a post-translational modification described over 50 years ago (1). Tyrosine-sulfated proteins and/or tyrosylprotein sulfotransferase activity have been described in many species in the plant and animal kingdoms (2, 3). In humans, dozens of tyrosine-sulfated proteins have been identified. These include certain adhesion molecules, G-protein-coupled receptors, coagulation factors, serpins, extracellular matrix proteins, hormones, and others. It has been demonstrated that some of these proteins require tyrosine sulfation for optimal function (3).In mice and humans, protein-tyrosine sulfation is mediated by one of two tyrosylprotein sulfotransferases called TPST-1² and TPST-2 (4–6). Mouse TPST-1 and TPST-2 are 370- and 376-residue type II transmembrane proteins, respectively. Each has a short N-terminal cytoplasmic domain followed by a single ≈17-residue transmembrane domain, a membrane proximal ≈40-residue stem region, and a luminal catalytic domain containing four conserved Cys residues and two N-glycosylation sites. The amino acid sequence of human and mouse TPST-1 are ≈96% identical and human and mouse TPST-2 have a similar degree of identity. TPST-1 is ≈65–67% identical to TPST-2 in both mice and humans. TPST-1 and TPST-2 are broadly expressed in human and murine tissues and cell lines and are co-expressed in most, if not all, cell types (3).A variety of biochemical studies have shown that protein-tyrosine sulfation occurs exclusively in the trans-Golgi network (7, 8). This conclusion has been strengthened by more recent immunofluorescence studies showing that a TPST-1/enhanced green fluorescent protein fusion protein co-localizes with golgin-97, a marker for the trans-Golgi network (9). Thus, protein-tyrosine sulfation occurs only on proteins that transit the secretory pathway and occurs well after protein folding and disulfide formation are complete and after N- and O-linked glycosylation are initiated.To gain an understanding of the biological importance of TPSTs, we have generated TPST-deficient mice by targeted disruption of either the Tpst1 or Tpst2 gene. Our studies of Tpst1^-/- mice revealed unexpected but modest effects on body weight and fecundity (10). Tpst1^-/- mice appear healthy but have ≈5% lower average body weight than wild type mice. Fertility of Tpst1^-/- males and females per se was normal. However, Tpst1^-/- females have smaller litters than wild type females due to embryonic lethality between 8.5 and 15.5 days post coitum.In our studies of Tpst2^-/- mice we found that Tpst2^-/- males were infertile, in contrast to Tpst1^-/- males that have normal fertility (11). We found that Tpst2^-/- males were eugonadal and have normal spermatogenesis. Epididymal sperm from Tpst2^-/- males were normal in number, morphology, and motility and appeared to capacitate in vitro and undergo acrosome exocytosis in response to agonist. However, Tpst2^-/- sperm are severely defective in motility in viscous media and in their ability to fertilize zona pellucida (ZP)-intact eggs. In addition, in vitro fertilization experiments revealed that Tpst2^-/- sperm had reduced ability to adhere to the egg plasma membrane, but were able to undergo membrane fusion with the egg.These findings suggest that tyrosine sulfation of one or more substrates is crucial for normal sperm function. However, there are no proteins directly involved in sperm function that are known to be tyrosine-sulfated. The luteinizing hormone receptor and follicle-stimulating hormone receptor are the only proteins important in reproductive biology that are known to be tyrosine-sulfated. Both receptors have been shown to be sulfated at a membrane proximal site in their respective N-terminal extracellular domains that are conserved in many species including the mouse (12). Sulfation of these receptors has been shown to be required for optimal affinity of their cognate ligands in vitro. However, our observations that serum LH, FSH, and testosterone levels are normal in Tpst2^-/- males coupled with the observation that spermatogenesis is normal excludes defective sulfation of these receptors as an explanation for infertility of Tpst2^-/- males (11).In this study, we sought to identify tyrosine-sulfated proteins expressed in the male genital tract that may provide clues as to the mechanism for the infertility of Tpst2^-/- male mice. Among the several candidate tyrosine-sulfated proteins that were identified, RNase 9 and Mfge8 were of particular interest. RNase 9 is a catalytically inactive RNase A family member of unknown function and is expressed only in the epididymis after onset of sexual maturity (13). Mfge8 is expressed on mouse sperm and Mfge8^-/- male mice have been reported to be subfertile (14). Metabolic labeling coupled with sulfoamino acid analysis confirmed that both proteins are tyrosine-sulfated. We also showed that both proteins are expressed at comparable levels in wild type, Tpst1^-/-, and Tpst2^-/- epididymides, and that RNase 9 and Mfge8 are sulfated in wild type and Tpst1^-/- mice, but not in Tpst2^-/- mice. Therefore, lack of sulfation of one or both of these proteins may contribute mechanistically to the infertility of Tpst2^-/- male mice.     

Changes in Hexokinase Activity in Echinochloa phyllopogon and Echinochloa crus-pavonis in Response to Abiotic Stress

Hexokinase (HXK; EC 2.7.1.1) regulates carbohydrate entry into glycolysis and is known to be a sensor for sugar-responsive gene expression. The effect of abiotic stresses on HXK activity was determined in seedlings of the flood-tolerant plant Echinochloa phyllopogon (Stev.) Koss and the flood-intolerant plant Echinochloa crus-pavonis (H.B.K.) Schult grown aerobically for 5 d before being subjected to anaerobic, chilling, heat, or salt stress. HXK activity was stimulated in shoots of E. phyllopogon only by anaerobic stress. HXK activity was only transiently elevated in E. crus-pavonis shoots during anaerobiosis. In roots of both species, anoxia and chilling stimulated HXK activity. Thus, HXK is not a general stress protein but is specifically induced by anoxia and chilling in E. phyllopogon and E. crus-pavonis. In both species HXK exhibited an optimum pH between 8.5 and 9.0, but the range was extended to pH 7.0 in air-grown E. phyllopogon to 6.5 in N₂-grown E. phyllopogon. At physiologically relevant pHs (6.8 and 7.3, N₂ and O₂ conditions, respectively), N₂-grown seedlings retained greater HXK activity at the lower pH. The pH response suggests that in N₂-grown seedlings HXK can function in a more acidic environment and that a specific isozyme may be important for regulating glycolytic activity during anaerobic metabolism in E. phyllopogon.     

Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser202 in Vitro

In Alzheimer disease (AD), frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) and other tauopathies, tau accumulates and forms paired helical filaments (PHFs) in the brain. Tau isolated from PHFs is phosphorylated at a number of sites, migrates as ∼60-, 64-, and 68-kDa bands on SDS-gel, and does not promote microtubule assembly. Upon dephosphorylation, the PHF-tau migrates as ∼50–60-kDa bands on SDS-gels in a manner similar to tau that is isolated from normal brain and promotes microtubule assembly. The site(s) that inhibits microtubule assembly-promoting activity when phosphorylated in the diseased brain is not known. In this study, when tau was phosphorylated by Cdk5 in vitro, its mobility shifted from ∼60-kDa bands to ∼64- and 68-kDa bands in a time-dependent manner. This mobility shift correlated with phosphorylation at Ser²⁰², and Ser²⁰² phosphorylation inhibited tau microtubule-assembly promoting activity. When several tau point mutants were analyzed, G272V, P301L, V337M, and R406W mutations associated with FTDP-17, but not nonspecific mutations S214A and S262A, promoted Ser²⁰² phosphorylation and mobility shift to a ∼68-kDa band. Furthermore, Ser²⁰² phosphorylation inhibited the microtubule assembly-promoting activity of FTDP-17 mutants more than of WT. Our data indicate that FTDP-17 missense mutations, by promoting phosphorylation at Ser²⁰², inhibit the microtubule assembly-promoting activity of tau in vitro, suggesting that Ser²⁰² phosphorylation plays a major role in the development of NFT pathology in AD and related tauopathies.Neurofibrillary tangles (NFTs)⁴ and senile plaques are the two characteristic neuropathological lesions found in the brains of patients suffering from Alzheimer disease (AD). The major fibrous component of NFTs are paired helical filaments (PHFs) (for reviews see Refs. 1–3). Initially, PHFs were found to be composed of a protein component referred to as “A68” (4). Biochemical analysis reveled that A68 is identical to the microtubule-associated protein, tau (4, 5). Some characteristic features of tau isolated from PHFs (PHF-tau) are that it is abnormally hyperphosphorylated (phosphorylated on more sites than the normal brain tau), does not bind to microtubules, and does not promote microtubule assembly in vitro. Upon dephosphorylation, PHF-tau regains its ability to bind to and promote microtubule assembly (6, 7). Tau hyperphosphorylation is suggested to cause microtubule instability and PHF formation, leading to NFT pathology in the brain (1–3).PHF-tau is phosphorylated on at least 21 proline-directed and non-proline-directed sites (8, 9). The individual contribution of these sites in converting tau to PHFs is not entirely clear. However, some sites are only partially phosphorylated in PHFs (8), whereas phosphorylation on specific sites inhibits the microtubule assembly-promoting activity of tau (6, 10). These observations suggest that phosphorylation on a few sites may be responsible and sufficient for causing tau dysfunction in AD.Tau purified from the human brain migrates as ∼50–60-kDa bands on SDS-gel due to the presence of six isoforms that are phosphorylated to different extents (2). PHF-tau isolated from AD brain, on the other hand, displays ∼60-, 64-, and 68 kDa-bands on an SDS-gel (4, 5, 11). Studies have shown that ∼64- and 68-kDa tau bands (the authors have described the ∼68-kDa tau band as an ∼69-kDa band in these studies) are present only in brain areas affected by NFT degeneration (12, 13). Their amount is correlated with the NFT densities at the affected brain regions. Moreover, the increase in the amount of ∼64- and 68-kDa band tau in the brain correlated with a decline in the intellectual status of the patient. The ∼64- and 68-kDa tau bands were suggested to be the pathological marker of AD (12, 13). Biochemical analyses determined that ∼64- and 68-kDa bands are hyperphosphorylated tau, which upon dephosphorylation, migrated as normal tau on SDS-gel (4, 5, 11). Tau sites involved in the tau mobility shift to ∼64- and 68-kDa bands were suggested to have a role in AD pathology (12, 13). It is not known whether phosphorylation at all 21 PHF-sites is required for the tau mobility shift in AD. However, in vitro the tau mobility shift on SDS-gel is sensitive to phosphorylation only on some sites (6, 14). It is therefore possible that in the AD brain, phosphorylation on some sites also causes a tau mobility shift. Identification of such sites will significantly enhance our knowledge of how NFT pathology develops in the brain.PHFs are also the major component of NFTs found in the brains of patients suffering from a group of neurodegenerative disorders collectively called tauopathies (2, 11). These disorders include frontotemporal dementia and Parkinsonism linked to chromosome 17 (FTDP-17), corticobasal degeneration, progressive supranuclear palsy, and Pick disease. Each PHF-tau isolated from autopsied brains of patients suffering from various tauopathies is hyperphosphorylated, displays ∼60-, 64-, and 68-kDa bands on SDS-gel, and is incapable of binding to microtubules. Upon dephosphorylation, the above referenced PHF-tau migrates as a normal tau on SDS-gel, binds to microtubules, and promotes microtubule assembly (2, 11). These observations suggest that the mechanisms of NFT pathology in various tauopathies may be similar and the phosphorylation-dependent mobility shift of tau on SDS-gel may be an indicator of the disease. The tau gene is mutated in familial FTDP-17, and these mutations accelerate NFT pathology in the brain (15–18). Understanding how FTDP-17 mutations promote tau phosphorylation can provide a better understanding of how NFT pathology develops in AD and various tauopathies. However, when expressed in CHO cells, G272V, R406W, V337M, and P301L tau mutations reduce tau phosphorylation (19, 20). In COS cells, although G272V, P301L, and V337M mutations do not show any significant affect, the R406W mutation caused a reduction in tau phosphorylation (21, 22). When expressed in SH-SY5Y cells subsequently differentiated into neurons, the R406W, P301L, and V337M mutations reduce tau phosphorylation (23). In contrast, in hippocampal neurons, R406W increases tau phosphorylation (24). When phosphorylated by recombinant GSK3β in vitro, the P301L and V337M mutations do not have any effect, and the R406W mutation inhibits phosphorylation (25). However, when incubated with rat brain extract, all of the G272V, P301L, V337M, and R406W mutations stimulate tau phosphorylation (26). The mechanism by which FTDP-17 mutations promote tau phosphorylation leading to development of NFT pathology has remained unclear.Cyclin-dependent protein kinase 5 (Cdk5) is one of the major kinases that phosphorylates tau in the brain (27, 28). In this study, to determine how FTDP-17 missense mutations affect tau phosphorylation, we phosphorylated four FTDP-17 tau mutants (G272V, P301L, V337M, and R406W) by Cdk5. We have found that phosphorylation of tau by Cdk5 causes a tau mobility shift to ∼64- and 68 kDa-bands. Although the mobility shift to a ∼64-kDa band is achieved by phosphorylation at Ser^396/404 or Ser²⁰², the mobility shift to a 68-kDa band occurs only in response to phosphorylation at Ser²⁰². We show that in vitro, FTDP-17 missense mutations, by promoting phosphorylation at Ser²⁰², enhance the mobility shift to ∼64- and 68-kDa bands and inhibit the microtubule assembly-promoting activity of tau. Our data suggest that Ser²⁰² phosphorylation is the major event leading to NFT pathology in AD and related tauopathies.     

Neocortex and Allocortex Respond Differentially to Cellular Stress In Vitro and Aging In Vivo

In Parkinson’s and Alzheimer’s diseases, the allocortex accumulates aggregated proteins such as synuclein and tau well before neocortex. We present a new high-throughput model of this topographic difference by microdissecting neocortex and allocortex from the postnatal rat and treating them in parallel fashion with toxins. Allocortical cultures were more vulnerable to low concentrations of the proteasome inhibitors MG132 and PSI but not the oxidative poison H₂O₂. The proteasome appeared to be more impaired in allocortex because MG132 raised ubiquitin-conjugated proteins and lowered proteasome activity in allocortex more than neocortex. Allocortex cultures were more vulnerable to MG132 despite greater MG132-induced rises in heat shock protein 70, heme oxygenase 1, and catalase. Proteasome subunits PA700 and PA28 were also higher in allocortex cultures, suggesting compensatory adaptations to greater proteasome impairment. Glutathione and ceruloplasmin were not robustly MG132-responsive and were basally higher in neocortical cultures. Notably, neocortex cultures became as vulnerable to MG132 as allocortex when glutathione synthesis or autophagic defenses were inhibited. Conversely, the glutathione precursor N-acetyl cysteine rendered allocortex resilient to MG132. Glutathione and ceruloplasmin levels were then examined in vivo as a function of age because aging is a natural model of proteasome inhibition and oxidative stress. Allocortical glutathione levels rose linearly with age but were similar to neocortex in whole tissue lysates. In contrast, ceruloplasmin levels were strikingly higher in neocortex at all ages and rose linearly until middle age. PA28 levels rose with age and were higher in allocortex in vivo, also paralleling in vitro data. These neo- and allocortical differences have implications for the many studies that treat the telencephalic mantle as a single unit. Our observations suggest that the topographic progression of protein aggregations through the cerebrum may reflect differential responses to low level protein-misfolding stress but also reveal impressive compensatory adaptations in allocortex.     

Clostridium difficile ribotypes in humans and animals in Brazil

Clostridium difficile is an emerging enteropathogen responsible for pseudomembranous colitis in humans and diarrhoea in several domestic and wild animal species. Despite its known importance, there are few studies aboutC. difficile polymerase chain reaction (PCR) ribotypes in Brazil and the actual knowledge is restricted to studies on human isolates. The aim of the study was therefore to compare C. difficileribotypes isolated from humans and animals in Brazil. Seventy-six C. difficile strains isolated from humans (n = 25), dogs (n = 23), piglets (n = 12), foals (n = 7), calves (n = 7), one cat, and one manned wolf were distributed into 24 different PCR ribotypes. Among toxigenic strains, PCR ribotypes 014/020 and 106 were the most common, accounting for 14 (18.4%) and eight (10.5%) samples, respectively. Fourteen different PCR ribotypes were detected among human isolates, nine of them have also been identified in at least one animal species. PCR ribotype 027 was not detected, whereas 078 were found only in foals. This data suggests a high diversity of PCR ribotypes in humans and animals in Brazil and support the discussion of C. difficile as a zoonotic pathogen.     

Nitrile-specifier Proteins Involved in Glucosinolate Hydrolysis in Arabidopsis thaliana

Glucosinolates are plant secondary metabolites present in Brassicaceae plants such as the model plant Arabidopsis thaliana. Intact glucosinolates are believed to be biologically inactive, whereas degradation products after hydrolysis have multiple roles in growth regulation and defense. The degradation of glucosinolates is catalyzed by thioglucosidases called myrosinases and leads by default to the formation of isothiocyanates. The interaction of a protein called epithiospecifier protein (ESP) with myrosinase diverts the reaction toward the production of epithionitriles or nitriles depending on the glucosinolate structure. Here we report the identification of a new group of nitrile-specifier proteins (AtNSPs) in A. thaliana able to generate nitriles in conjunction with myrosinase and a more detailed characterization of one member (AtNSP2). Recombinant AtNSP2 expressed in Escherichia coli was used to test its impact on the outcome of glucosinolate hydrolysis using a gas chromatography-mass spectrometry approach. AtNSP proteins share 30–45% sequence homology with A. thaliana ESP. Although AtESP and AtNSP proteins can switch myrosinase-catalyzed degradation of 2-propenylglucosinolate from isothiocyanate to nitrile, only AtESP generates the corresponding epithionitrile. Using the aromatic benzylglucosinolate, recombinant AtNSP2 is also able to direct product formation to the nitrile. Analysis of glucosinolate hydrolysis profiles of transgenic A. thaliana plants overexpressing AtNSP2 confirms its nitrile-specifier activity in planta. In silico expression analysis reveals distinctive expression patterns of AtNSPs, which supports a biological role for these proteins. In conclusion, we show that AtNSPs belonging to a new family of A. thaliana proteins structurally related to AtESP divert product formation from myrosinase-catalyzed glucosinolate hydrolysis and, thereby, likely affect the biological consequences of glucosinolate degradation. We discuss similarities and properties of AtNSPs and related proteins and the biological implications.Brassicaceae plants such as oilseed rape (Brassica napus), turnip (Brassica rapa), and white mustard (Sinapis alba) as well as the model plant Arabidopsis thaliana contain a group of secondary metabolites known as glucosinolates (GSLs)² (1, 2). These are β-thioglucoside N-hydroxysulfates with a sulfur-linked β-d-glucopyranose moiety and a variable side chain that is derived from one of eight amino acids or their methylene group-elongated derivatives. Aliphatic GSLs are derived from alanine, leucine, isoleucine, valine, or predominantly methionine. Tyrosine or phenylalanine give aromatic GSLs, and tryptophan-derived GSLs are called indolic GSLs (for review, see Ref. 3). Although more than 120 different GSLs have been identified in total so far, individual plant species usually contain only a few GSLs (2). Quantitative and qualitative differences of GSL profiles are also observed within a species, such as, for example, for different A. thaliana ecotypes (4–6). In addition, GSL composition varies among organs and during the life cycle of plants (7, 8) and is affected by external factors (9).Intact GSLs are mostly considered to be biologically inactive. Most GSL degradation products have toxic effects on insect, fungal, and bacterial pests, serve as attractants for specialist insects, or may have beneficial health effects for humans (10–15). The enzymatic degradation of GSLs (Fig. 1A), which occurs massively upon tissue damage, is catalyzed by plant thioglucosidases called myrosinases (EC 3.2.1.147; glycoside hydrolase family 1). Depending on several factors (e.g. GSL structure, proteins, cofactors, pH) myrosinase-catalyzed hydrolysis of GSLs can lead to a variety of products (Fig. 1B; for review, see Refs. 16 and 17). Of these, isothiocyanates are the most common as their formation only requires myrosinase activity. Thiocyanates on the other hand are only produced from a very limited number of GSLs, and their formation necessitates the presence of a thiocyanate-forming factor in addition to myrosinase (18). A thiocyanate-forming protein (TFP) has recently been identified in Lepidium sativum (19). Alkenyl GSLs, a subgroup of aliphatic GSLs containing a terminal unsaturation in their side chain, can lead to the production of epithionitriles through the cooperative action of myrosinase and a protein called epithiospecifier protein (ESP (20)) in a ferrous ion-dependent way (21–23). Both TFP and ESP contain a series of Kelch repeats (19). Kelch repeats are involved in protein-protein interactions, and Kelch repeat-containing proteins are involved in a number of diverse biological processes (24). In addition to isothiocyanates, nitriles are the major group of GSL hydrolysis products. Although ESP and TFP activities can generate nitriles (19, 21, 25, 26), indications for an ESP-independent nitrile-specifier activity exist. The GSL hydrolysis profile of A. thaliana roots, an organ that does not show ESP expression or activity (27), reveals predominantly the presence of nitriles (28). In addition, leaf tissue of A. thaliana ecotypes supposedly devoid of ESP activity produces a certain amount of nitriles upon autolysis (21). Under acidic buffer conditions, a non-enzymatic production of nitriles from GSLs is observed (Ref. 29 and references therein). Increasing Fe²⁺ concentrations have also been shown to favor nitrile formation over isothiocyanate formation from a number of GSLs in the presence of myrosinase and absence of ESP (21, 22). Therefore, a non-enzymatic origin of this nitrile production cannot be excluded, although the presence of a nitrile-specifier protein is a tempting alternative. Although ESP is able to generate nitriles, it has also been shown that the conversion rates of GSLs to nitriles are lower than those of GSLs to epithionitriles for ESP (21, 22).Open in a separate windowFIGURE 1.Simplified scheme of enzymatic GSL hydrolysis (A) and structures and names of GSLs and their hydrolysis products that are mentioned in the article. (B). A, myrosinase acts on GSLs to form an unstable aglycone intermediate that can rearrange spontaneously to form an isothiocyanate. Hydrolysis can be diverted from this default route under certain conditions (e.g. the presence of NSPs, ferrous ions, or at pH < 5) to give the corresponding nitrile. ESP is responsible for the formation of epithionitriles from alkenyl GSLs in a ferrous ion-dependent mechanism. B, the general structure of GSLs, indicating the variable side chain as R, is given as well as the three major classes of hydrolysis products (i.e. isothiocyanates, nitriles, and epithionitriles). The listed GSLs are the ones mentioned in this article and are arranged according to the class of GSLs they belong to and with an increase in chain length or complexity. The names of the respective hydrolysis products are given for a better understanding of the present article, and not all were encountered during our studies.A nitrile-specifier protein (NSP) that is able to redirect the hydrolysis of GSLs toward nitriles has been cloned from the larvae of the butterfly Pieris rapae (30). This protein does not, however, exhibit sequence similarity to plant ESP, and a corresponding plant nitrile-specifier protein has not yet been identified. We report here the identification of a group of six A. thaliana genes with some sequence similarity to A. thaliana ESP, providing evidence for a new family of nitrile-specifier proteins and a more detailed characterization of one member that possesses nitrile-specifier activity in vitro, when applied exogenously to plant tissue and after ectopic expression in the two A. thaliana ecotypes Col-0 and C24. Despite its sequence homology to A. thaliana epithiospecifier protein (AtESP), it does not possess epithiospecifier activity under similar conditions. Therefore, we propose to designate this protein as A. thaliana nitrile-specifier protein 2 (AtNSP2). Although the biological roles of AtNSP2 and related proteins are not yet known, their specificities and distinctive expression patterns indicate the presence of a fine-tuned mechanism for GSL degradation controlling the outcome of an array of biologically active molecules.     

G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D2 Dopamine Receptor

We investigated the role of G protein-coupled receptor kinase (GRK)-mediated phosphorylation in agonist-induced desensitization, arrestin association, endocytosis, and intracellular trafficking of the D₂ dopamine receptor (DAR). Agonist activation of D₂ DARs results in rapid and sustained receptor phosphorylation that is solely mediated by GRKs. A survey of GRKs revealed that only GRK2 or GRK3 promotes D₂ DAR phosphorylation. Mutational analyses resulted in the identification of eight serine/threonine residues within the third cytoplasmic loop of the receptor that are phosphorylated by GRK2/3. Simultaneous mutation of these eight residues results in a receptor construct, GRK(-), that is completely devoid of agonist-promoted GRK-mediated receptor phosphorylation. We found that both wild-type (WT) and GRK(-) receptors underwent a similar degree of agonist-induced desensitization as assessed using [³⁵S]GTPγS binding assays. Similarly, both receptor constructs internalized to the same extent in response to agonist treatment. Furthermore, using bioluminescence resonance energy transfer assays to directly assess receptor association with arrestin3, we found no differences between the WT and GRK(-) receptors. Thus, phosphorylation is not required for arrestin-receptor association or agonist-induced desensitization or internalization. In contrast, when we examined recycling of the D₂ DARs to the cell surface, subsequent to agonist-induced endocytosis, the GRK(-) construct exhibited less recycling in comparison with the WT receptor. This impairment appears to be due to a greater propensity of the GRK(-) receptors to down-regulate once internalized. In contrast, if the receptor is highly phosphorylated, then receptor recycling is promoted. These results reveal a novel role for GRK-mediated phosphorylation in regulating the post-endocytic trafficking of a G protein-coupled receptor.Dopamine receptors (DARs)³ are members of the GPCR superfamily and consist of five structurally distinct subtypes (1, 2). These can be divided into two subfamilies on the basis of their structure and pharmacological and transductional properties (3). The “D₁-like” subfamily includes the D₁ and D₅ receptors, which couple to the heterotrimeric G proteins G_S or G_OLF to stimulate adenylyl cyclase activity and raise intracellular levels of cAMP. The D₂-like subfamily includes the D₂, D₃, and D₄ receptors, which couple to inhibitory G_i/o proteins to reduce adenylyl cyclase activity as well as modulate voltage-gated K⁺ or Ca²⁺ channels. Within the central nervous system, these receptors modulate movement, learning and memory, reward and addiction, cognition, and certain neurendocrine functions. As with other GPCRs, the DARs are subject to a wide variety of regulatory mechanisms, which can either positively or negatively modulate their expression and functional activity (4).Upon agonist activation, most GPCRs undergo desensitization, a homeostatic process that results in a waning of receptor response despite continued agonist stimulation (5, 6). Desensitization is believed to involve the phosphorylation of receptors by either G protein-coupled receptor kinases (GRKs) and/or second messenger-activated kinases such as PKA or PKC. Homologous forms of desensitization involve only agonist-activated receptors and appear to be primarily mediated by GRKs. In many cases, GRK-mediated phosphorylation has been shown to decrease receptor/G protein interactions and also initiate arrestin binding, which further promotes endocytosis of the receptor through clathrin-coated pits (7–9). Once internalized, GPCRs can engage additional signaling pathways (10), be sorted for recycling to the plasma membrane, or targeted for degradation (7–9). Among the DARs, the D₂ receptor is arguably one of the most validated drug targets in neurology and psychiatry. For instance, all receptor-based anti-parkinsonian drugs work via stimulating the D₂ DAR (11), whereas all Food and Drug Administration-approved antipsychotic agents are antagonists of this receptor subtype (12, 13). The D₂ DAR is also therapeutically targeted in other disorders such as restless legs syndrome, tardive dyskinesia, Tourette syndrome, and hyperprolactinemia. As such, more knowledge concerning the regulation of the D₂ DAR could be helpful in improving current therapies or devising new treatment strategies.In comparison with other GPCRs, however, detailed mechanistic information concerning regulation of the D₂ DAR is mostly lacking, although some progress has recently been made. For instance, we (14) and others (15) have found that PKC-mediated phosphorylation can regulate both D₂ receptor desensitization and trafficking. In our PKC study, we mapped out all of the PKC phosphorylation sites within the third intracellular loop (IC3) of the receptor, and we determined the existence of two PKC phosphorylation domains. Both of these domains were found to regulate receptor sequestration, whereas only one domain regulated functional uncoupling in response to PKC activation (14). In response to agonist activation, the D₂ DAR has also been shown to undergo functional desensitization (4), although this has not been intensively investigated. More thoroughly examined is the observation that agonist stimulation of the D₂ DAR promotes its sequestration from the cell surface into vesicular compartments that appear distinct from those harboring internalized D₁ DARs or β-adrenergic receptors (16–21). In addition to uncertainty over the endocytic pathway involved, controversy also exists as to whether or not D₂ DAR internalization is dynamin-dependent and whether the internalized receptors can partially or completely recycle to the cell surface or, alternatively, if they undergo degradation (19, 21–24). The D₂ DAR does appear to undergo GRK-mediated phosphorylation upon agonist activation, which has been suggested to promote arrestin association and receptor sequestration (16, 19, 25), although this process has not been studied in detail and its relationship to functional receptor desensitization is unknown.In this study, we have further characterized GRK-mediated phosphorylation of the D₂ DAR and determined its role in agonist-induced receptor desensitization, internalization, and recycling. Using site-directed mutagenesis, we have mapped out all of the GRK phosphorylation sites within the D₂ DAR and determined that these are distinct from the PKC phosphorylation sites. Using a GRK phosphorylation-null mutant receptor, we found, surprisingly, that GRK-mediated phosphorylation is not actually required for agonist-induced receptor desensitization, arrestin association, or internalization. In contrast, we found that the GRK phosphorylation-null receptor was impaired in its ability to recycle to the cell surface subsequent to internalization and was degraded to a greater extent in comparison with the wild-type receptor. These results suggest that GRK-mediated phosphorylation of the D₂ DAR regulates its intracellular trafficking or sorting once internalized, a novel mechanism for GRK-mediated regulation of GPCR function.     

In Vivo and In Vitro Characterization of a Plasmodium Liver Stage-Specific Promoter

Little is known about stage-specific gene regulation in Plasmodium parasites, in particular the liver stage of development. We have previously described in the Plasmodium berghei rodent model, a liver stage-specific (lisp2) gene promoter region, in vitro. Using a dual luminescence system, we now confirm the stage specificity of this promoter region also in vivo. Furthermore, by substitution and deletion analyses we have extended our in vitro characterization of important elements within the promoter region. Importantly, the dual luminescence system allows analyzing promoter constructs avoiding mouse-consuming cloning procedures of transgenic parasites. This makes extensive mutation and deletion studies a reasonable approach also in the malaria mouse model. Stage-specific expression constructs and parasite lines are extremely valuable tools for research on Plasmodium liver stage biology. Such reporter lines offer a promising opportunity for assessment of liver stage drugs, characterization of genetically attenuated parasites and liver stage-specific vaccines both in vivo and in vitro, and may be key for the generation of inducible systems.     

In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi

Background

Cruzain, the major cysteine protease of Trypanosoma cruzi, is an essential enzyme for the parasite life cycle and has been validated as a viable target to treat Chagas'' disease. As a proof-of-concept, K11777, a potent inhibitor of cruzain, was found to effectively eliminate T. cruzi infection and is currently a clinical candidate for treatment of Chagas'' disease.

Methodology/Principal Findings

WRR-483, an analog of K11777, was synthesized and evaluated as an inhibitor of cruzain and against T. cruzi proliferation in cell culture. This compound demonstrates good potency against cruzain with sensitivity to pH conditions and high efficacy in the cell culture assay. Furthermore, WRR-483 also eradicates parasite infection in a mouse model of acute Chagas'' disease. To determine the atomic-level details of the inhibitor interacting with cruzain, a 1.5 Å crystal structure of the protease in complex with WRR-483 was solved. The structure illustrates that WRR-483 binds covalently to the active site cysteine of the protease in a similar manner as other vinyl sulfone-based inhibitors. Details of the critical interactions within the specificity binding pocket are also reported.

Conclusions

We demonstrate that WRR-483 is an effective cysteine protease inhibitor with trypanocidal activity in cell culture and animal model with comparable efficacy to K11777. Crystallographic evidence confirms that the mode of action is by targeting the active site of cruzain. Taken together, these results suggest that WRR-483 has potential to be developed as a treatment for Chagas'' disease.